[Latest] Global Tourism Source Market Size/Share Worth USD 986.5 Billion by 2032 at a 5.2% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
October 18, 2023 17:30 ET
|
Custom Market Insights
Austin, TX, USA, Oct. 19, 2023 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Tourism Source Market Size, Trends and Insights By Booking Channel (Websites,...
Persbericht Biocartis Group NV: Biocartis steunt Borstkankermaand met lancering van een borstkankerportfolio
October 16, 2023 01:00 ET
|
Biocartis NV
PERSBERICHT 16 oktober 2023, 7:00 CEST Biocartis steunt Borstkankermaand met lancering van een borstkankerportfolio Mechelen, België, 16 oktober 2023 - Biocartis Group NV (de 'Vennootschap' of...
Press release Biocartis Group NV: Biocartis Honors Breast Cancer Awareness Month with Launch of Breast Cancer Portfolio
October 16, 2023 01:00 ET
|
Biocartis NV
PRESS RELEASE 16 October 2023, 7:00 CEST Biocartis Honors Breast Cancer Awareness Month with Launch of Breast Cancer Portfolio Mechelen, Belgium, 16 October 2023 – Biocartis Group NV (the ‘Company’...
Persbericht Biocartis Group NV: Biocartis kondigt uitbreiding aan van de samenwerking met APIS Assay Technologies en zal de APIS ESR1 Mutations Kit commercialiseren
October 12, 2023 01:00 ET
|
Biocartis NV
PERSBERICHT 12 oktober 2023, 7:00 CEST Biocartis kondigt uitbreiding aan van de samenwerking met APIS Assay Technologies en zal de APIS ESR1 Mutations Kit commercialiseren Mechelen, België, 12...
Press release Biocartis Group NV: Biocartis Announces Expansion of its Collaboration with APIS Assay Technologies to Commercialize the APIS ESR1 Mutations Kit
October 12, 2023 01:00 ET
|
Biocartis NV
PRESS RELEASE 12 October 2023, 7:00 CEST Biocartis Announces Expansion of its Collaboration with APIS Assay Technologies to Commercialize the APIS ESR1 Mutations Kit Mechelen, Belgium, 12 October...
Persbericht Biocartis Group NV: Openbaarmaking van transparantiekennisgeving
October 03, 2023 01:00 ET
|
Biocartis NV
PERSBERICHT: GEREGLEMENTEERDE INFORMATIE3 oktober 2023, 7:00 CEST Openbaarmaking van transparantiekennisgeving Mechelen, België, 3 oktober 2023 – Biocartis Group NV (de ‘Vennootschap’ of...
Press Release Biocartis Group NV: Disclosure of transparency notification
October 03, 2023 01:00 ET
|
Biocartis NV
PRESS RELEASE: REGULATED INFORMATION 3 October 2023, 7:00 CEST Disclosure of transparency notification Mechelen, Belgium, 3...
Press Release Biocartis Group NV: Biocartis announces H1 2023 Results and provides an update on the operational reorganization and recapitalization
September 26, 2023 01:00 ET
|
Biocartis NV
PRESS RELEASE: INSIDE INFORMATION / REGULATED INFORMATION 26 September 2023, 07:00 CEST BIOCARTIS ANNOUNCES H1 2023 RESULTS AND PROVIDES AN UPDATE ON THE OPERATIONAL REORGANIZATION AND...
Persbericht Biocartis Group NV: Overeenkomst betreffende herkapitalisatie van operationele dochteronderneming door gewaarborgde schuldeisers en liquidatie van beursgenoteerde holdingmaatschappij
September 26, 2023 01:00 ET
|
Biocartis NV
PERSBERICHT: VOORKENNIS / GEREGULEERDE INFORMATIE 26 september 2023, 07:00 CEST OVEREENKOMST BETREFFENDE HERKAPITALISATIE VAN OPERATIONELE DOCHTERONDERNEMINGEN DOOR GEWAARBORGDE SCHULDEISERS EN...
Press Release Biocartis Group NV: Agreement regarding recapitalization of operating subsidiaries by secured by secured creditors and wind down of listed holding company
September 26, 2023 01:00 ET
|
Biocartis NV
PRESS RELEASE:INSIDE INFORMATION / REGULATED INFORMATION 26 September 2023, 07:00 CEST AGREEMENT REGARDING RECAPITALIZATION OF OPERATING SUBSIDIARIES BY SECURED CREDITORS AND WIND DOWN OF LISTED...